Recurrent stroke in a child with TRMA syndrome and SLC19A2 gene mutation
Iranian Journal of Child Neurology,
Vol. 12 No. 1 (2018),
Here we report a 5-month-old boy with thiamine Responsive Megaloblastic Anemia syndrome (TRMA syndrome) with several attacks of stroke. In addition to the cardinal clinical manifestations of the syndrome (thiamine-responsive megaloblastic anemia, diabetes mellitus, and sensor neural hearing loss), the patient showed the ischemic attack of stroke. Megaloblastic anemia and Diabetes were diagnosed at 8 months and was successfully treated with vitamin and insulin prescription. After treatment of thiamine diabetes was controlled and insulin was discontinued. In spite of the thiamine administration, the second stroke as hemorrhagic stroke was occurred in the patient after a few months. TRAMA is inherited in an autosomal recessive manner. TRMA was confirmed by mutation in SLC19A2. A homozygous splice site variant was detected in SLC19A2 gene. According to our knowledge stroke was not reported in this syndrome (only in one report about one attack in an adult patient) but in this patient several attacks of stroke was report before and after thiamin administration.
- Thiamine Responsive Megaloblastic Anemia
- stroke. Infant
How to Cite
Poggi V, Longo G, DeVizia B, Andria G, Rindi G, Patrini C, et al. Thiamin-responsive megaloblastic anaemia: a disorder of thiamin transport? Organic Acidurias: Springer; 1984. p. 153-4.
Bergmann AK, Sahai I, Falcone JF, Fleming J, Bagg A, Borgna-Pignati C, et al. Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. The Journal of pediatrics. 2009;155(6):888-92. e1.
Lagarde WH, Underwood LE, Moats‐Staats BM, Calikoglu AS. Novel mutation in the SLC19A2 gene in an African‐American female with thiamine‐responsive megaloblastic anemia syndrome. American Journal of Medical Genetics Part A. 2004;125(3):299-305.
Olsen BS, Hahnemann J, Schwartz M, Østergaard E. Thiamine‐responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood. Pediatric diabetes. 2007;8(4):239-41.
Yeşilkaya E, Bideci A, Temizkan M, Kaya Z, Çamurdan O, Koç A, et al. A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome. Journal of tropical pediatrics. 2009;55(4):265-7.
Villa V, Rivellese A, Di Salle F, Iovine C, Poggi V, Capaldo B. Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome. The Journal of Clinical Endocrinology & Metabolism. 2000;85(3):947-9.
Valerio G, Franzese A, Poggi V, Tenore A. Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. Diabetes Care. 1998;21(1):38-41.
Rogers LE, Porter FS, Sidbury JB. Thiamine-responsive megaloblastic anemia. The Journal of pediatrics. 1969;74(4):494-504.
Viana MB, Carvalho RI. Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: a new syndrome? The Journal of pediatrics. 1978;93(2):235-8.
Abboud MR, Alexander D, Najjar SS. Diabetes mellitus, thiamine-dependentmegaloblastic anemia, and sensorineural deafness associated with deficient α-ketoglutarate dehydrogenase activity. The Journal of pediatrics. 1985;107(4):537-41.
Setoodeh A, Haghighi A, Saleh-Gohari N, Ellard S, Haghighi A. Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia. Gene. 2013;519(2):295-7.
- Abstract Viewed: 165 times
- PDF Downloaded: 90 times